Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmaceutical Innovation is Scopus-indexed (Q2, CiteScore 3.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 1872-5120Verify ISSN ↗1939-8042Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$3,990 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 89 / 191 | 53rd | Q2 |
| Drug Discovery | 106 / 161 | 34th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q2, CiteScore 3.5.
Journal of Pharmaceutical Innovation is Q2 in Pharmaceutical Science (rank 89 of 191) and Q3 in Drug Discovery (rank 106 of 161), by CiteScore 2025.
Journal of Pharmaceutical Innovation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.367, quartile Q3, with an H-index of 43.
The publisher lists an article processing charge of about US$3,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Pharmaceutical Innovation is published by Springer. Its print ISSN is 1872-5120 and its online ISSN is 1939-8042.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Pharmaceutical Innovation has an h-index of 48 and a 2-year mean of 1.13 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q2. On 2-year citations it ranks #110 of 177 Scopus journals in Pharmaceutical Science.
Journal of Pharmaceutical Innovation published 384 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from India (46.8%), China (11.6%) and Iran (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.